| Table 2. Comparison of the effects of AL and placebo on biochemical characteristics of women with PCOS. | |||||
| Variables | Arctium lappa L. (n=30) | Placebo (n=30) | p-value* | p-value § | Partial eta square† (ηp2) |
|---|---|---|---|---|---|
| SOD (U/ml) Before After p-value** |
339.17±6.34 400.37±15.83 <0.001 |
324.46±11.04 336.05±6.56 0.39 |
0.25 <0.001 |
<0.001 | 0.20 |
| CAT (KU) Before After p-value** |
6.15±0.64 8.74±0.47 <0.001 |
6.40±0.56 6.68±0.39 0.69 |
0.76 <0.001 |
<0.001 | 0.16 |
| GPx (mU/ml) Before After p-value** |
245.04±2.22 252.57±0.46 <0.001 |
244.43±2.41 245.33±1.59 0.76 |
0.85 <0.001 |
<0.001 | 0.25 |
| GSH (µM) Before After p-value** |
6.91±0.51 22.89±1.75 <0.001 |
6.20±0.96 15.85±2.15 <0.001 |
0.52 0.01 |
0.02 | 0.10 |
| GSSG (µM) Before After p-value** |
0.447±0.040 0.355±0.030 0.01 |
0.445±0.037 0.443±0.029 0.96 |
0.98 0.04 |
0.02 | 0.09 |
| GSH/GSSG Before After p-value** |
17.56±1.72 76.20±7.51 <0.001 |
15.09±2.35 43.56±9.52 0.01 |
0.40 0.01 |
0.01 | 0.11 |
| TAC (mM) Before After p-value** |
0.71±0.03 1.05±0.04 <0.001 |
0.70±0.03 0.66±0.02 0.23 |
0.77 <0.001 |
<0.001 | 0.56 |
| TOS (µM) Before After p-value** |
12.19±1.17 8.05±0.62 <0.001 |
13.23±1 14.21±1.01 0.40 |
0.50 <0.001 |
<0.001 | 0.32 |
| OSI % Before After p-value** |
1.83±0.13 0.78±0.06 <0.001 |
2±0.15 2.23±0.17 0.24 |
0.39 <0.001 |
<0.001 | 0.53 |
| MDA (µM) Before After p-value** |
4.57±0.47 2.45±0.25 <0.001 |
4.42±0.58 5.67±0.79 0.26 |
0.84 <0.001 |
<0.001 | 0.21 |
| MDA/TAC Before After p-value** |
0.0066±0.0006 0.0024±0.0002 <0.001 |
0.0065±0.0009 0.0087±0.0014 0.23 |
0.95 <0.001 |
<0.001 | 0.25 |
| TAG (µM) Before After p-value** |
(-128.06)±29/79 75.67±39/55 <0.001 |
(-169.53)±29.14 (-242.79)±22.25 0.04 |
0.32 <0.001 |
<0.001 | 0.45 |
| TT (mM) Before After p-value** |
0.157±0.006 0.198±0.009 <0.001 |
0.169±0.007 0.162±0.004 0.44 |
0.22 <0.001 |
<0.001 | 0.18 |
| CRP (mg/dl) Before After p-value** |
0.457±0.043 0.310±0.035 <0.001 |
0.463±0.044 0.447±0.039 0.66 |
0.91 0.01 |
<0.001 | 0.17 |
| CAR (mg/g) Before After p-value** |
0.099±0.011 0.058±0.007 <0.001 |
0.097±0.009 0.093±0.008 0.64 |
0.87 <0.001 |
<0.001 | 0.27 |
| BAR (mg/g) Before After p-value** |
4.82±0.14 2.95±0.12 <0.001 |
4.87±0.11 4.85±0.10 0.89 |
0.82 <0.001 |
<0.001 | 0.74 |
| ALBI Before After p-value** |
(-3.46)±0.09 (-4.07)±0.10 <0.001 |
(-3.41)±0.04 (-3.45)±0.05 0.33 |
0.63 <0.001 |
<0.001 | 0.36 |
| TyG Before After p-value** |
9.135±0.093 8.768±0.090 <0.001 |
9.182±0.083 8.999±0.077 <0.001 |
0.71 0.06 |
<0.001 | 0.33 |
Data presented as Mean ± SEM. A significance level of 0.05 was considered (p-value < 0.05).* independent t-test, ** paired t-test, § ANCOVA, † Partial eta square for ANCOVA. Arctium lappa L. (AL), Polycystic ovary syndrome (PCOS), Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GPx), Reduced glutathione (GSH), Oxidized glutathione (GSSG), Total antioxidant capacity (TAC), Total oxidant status (TOS), Oxidative stress index (OSI), Malondialdehyde (MDA), Total antioxidant gap (TAG), Total thiol (TT), C-reactive protein (CRP), CRP/albumin ratio (CAR), Bun/albumin ratio (BAR), Albumin-bilirubin score (ALBI), Triglyceride glucose index (TyG).